Pinsent Masons LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Renowned for its expertise and creativity in patent advice, strategy, and litigation, Pinsent Masons LLP’s life sciences and healthcare team is equally recognised for its ‘excellence’ in transactional, regulatory, and product liability matters. The firm is well-equipped to advise on EU and UK competition issues, including merger control and antitrust investigations. The team is co-led by Charlotte Weekes, a seasoned litigator praised for her understanding of business needs and practical advice on pharma product strategies, including pan-EU patent and SPC litigation. Fellow co-chair Joanne Ellis specialises in healthcare private equity, M&A, investments, and refinancing. Allistair Booth brings vast experience handling high-value licensing, collaboration, and partnering transactions, while ’proactive’ Catherine Drew provides regulatory and litigation advice to multinational pharma companies in the biosimilar and generic spaces. Robert Vidal and Clare Tunstall are no longer at the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Catherine Drew is always responsive, proactive strategic thinker, knows the industry inside out, excellent quality work with excellent turnaround times. A pleasure to work with.’
- ‘Charlotte Weekes is a very seasoned litigator, standing out against other litigators in that she understands the needs/requirements of senior management in the pharma business and how in-house counsel needs to deliver advice. She can provide both detailed, lege artis legal analysis backed up by research and detailed write-ups, and ad hoc/ brainstorming type analysis of many options. Unlike other competitors, she does not practice law in an ivory tower of legal doctrine and case law, but she applies the law to real-life situations and copes very well with the uncertainties and changes that come along with developing business projects. We were also impressed by Ian Turner's ability to handle very complex situations in a multi-party litigation. He broke down the complex procedures into digestible and manageable steps and he earned our trust with sound advice on next steps/options. We trusted him as he understood the ultimate business goals/needs, and thus we did not have to re-validate the suggested options, which is often the case for other competitors (e.g., other competitors often suggest theoretical, expensive, slow or risky options, just for the sake of it).’
Key clients
- Abbott Product Operations AG
- Accord
Work highlights
Representing Accord Healthcare and Sandoz against Bayer in proceedings relating to a dosing regimen patent for Xarelto (Rivaroxaban).